Jiangxi Fushine Pharmaceutical Co., Ltd. (300497.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap8.02B
Enterprise Value8.92B
P/E Ratio-92.52
PEG Ratio-3.75
Price/Sales Ratio7.03
Price/Book Ratio4.08
Enterprise/Revenue7.85
Enterprise/EBITDA57.07

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0
Operating Margin0.01
AD

Management Effectiveness

Return On Assets0
Return On Equity0

Income Statement

Revenue1.18B
Revenue/Share2.44
Gross Profit151.26M
EBITDA145.68M
Net Income-55.03M
Diluted EPS-0.1

Balance Sheet

Total Cash472.32M
Total Cash/Share0.88
Total Debt1.55B
Total Debt/Equity0.69
Current Ratio1.22
Book Value Per Share4.23

Price History

52-Week Change70.97
52-Week High24.18
52-Week Low9.4
Moving Average 50 Days18.11
Moving Average 200 Days16.01

Statistics

Average Volume47.54M
Shares Outstanding538.65M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio10.33
Last Split Factor8:5
Last Split DateMay 18, 2020
AD